CHEOF vs BSX: Which Stock is Better?
Side-by-side comparison of Cochlear Limited and Boston Scientific Corp in 2026
CHEOF
Cochlear Limited
$125.00
BSX
Boston Scientific Corp
$64.23
Key Metrics Comparison
| Metric | CHEOF | BSX | Winner |
|---|---|---|---|
| Market Cap | $11.64B | $94.25B | BSX |
| P/E Ratio | 47.34 | 32.69 | BSX |
| EPS (TTM) | $3.76 | $1.94 | CHEOF |
| Revenue Growth | -0.0% | 0.2% | BSX |
| Gross Margin | 72.8% | 68.8% | CHEOF |
Analyze CHEOF
Full quant analysis
Analyze BSX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHEOF or BSX a better investment?
Comparing CHEOF and BSX: Cochlear Limited has a market cap of $11.64B while Boston Scientific Corp has $94.25B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHEOF and BSX?
CHEOF (Cochlear Limited) and BSX (Boston Scientific Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHEOF or BSX?
Based on P/E ratios, BSX trades at a lower multiple (32.7x vs 47.3x).
Which is growing faster: CHEOF or BSX?
BSX has higher revenue growth at 0.2% vs -0.0% for CHEOF.
Which company is more profitable: CHEOF or BSX?
Cochlear Limited (CHEOF) has higher gross margins at 72.8% compared to 68.8% for BSX.
Which is the larger company: CHEOF or BSX?
Boston Scientific Corp (BSX) is larger with a market cap of $94.25B compared to $11.64B for CHEOF.
Should I buy CHEOF or BSX in 2026?
Both CHEOF and BSX have investment merit. CHEOF trades at $125.00 while BSX trades at $64.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHEOF and BSX stock?
Key differences: Market Cap ($11.64B vs $94.25B), P/E Ratio (47.3x vs 32.7x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (72.8% vs 68.8%).